Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02120261 · ClinicalTrials.gov registry record · Phase 4
Using Saline for Myofascial Pain Syndromes (USAMPS)
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 4
- Development phase
- 51
- Enrollment target
NCT02120261 is a Phase 4 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 51 participants.
The verdict
NCT02120261, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 51 participants
- Enrollment target
Study Summary
This study involves adult patients diagnosed with Myofascial Pain Syndromes (MPS). The purpose of this research study is to determine if there is a therapeutic difference between trigger point injection (TPI) of normal saline and conventional drug mix (local anesthesic + steroid) in treating MPS.
Interventions
- DRUG Normal Saline
- DRUG Lidocaine Hydrochloride
- DRUG Triamcinolone acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02120261
The ClinicalTrials.gov registry entry for NCT02120261 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Normal Saline is the first listed.
NCT02120261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02120261 about?
NCT02120261 is a clinical study titled "Using Saline for Myofascial Pain Syndromes (USAMPS)". This study involves adult patients diagnosed with Myofascial Pain Syndromes (MPS). The purpose of this research study is to determine if there is a therapeutic difference between trigger point injection (TPI) of normal saline and conventional drug mix (local anesthesic + steroid) in treating MPS.
What is the current status of trial NCT02120261?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2014-05. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02120261?
The interventions under investigation include: Normal Saline (DRUG), Lidocaine Hydrochloride (DRUG), Triamcinolone acetonide (DRUG).
Who is sponsoring clinical trial NCT02120261?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.